MedPath

Dose-finding study of AJG533 in patients with chronic constipation (Phase 2 study)

Phase 2
Conditions
Chronic constipation
Registration Number
JPRN-jRCT2080222557
Lead Sponsor
AJINOMOTO PHARMACEUTICALS CO.,LTD.
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Sex
All
Target Recruitment
Not specified
Inclusion Criteria

Patients with chronic constipation

Exclusion Criteria

Patient with known or suspected organic constipation
Patient with known or suspected symptomatic constipation or drug-induced constipation

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Frequency of Spontaneous Bowel Movement
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath